Hundreds of drugs may be suspended in EU after flawed tests
London
THE European Medicines Agency called for a halt to sales of hundreds of medicines that were tested in India, after an inspection of the research site found "substitution and manipulation" of study samples.
The recommendation applies to mostly generic medicines from companies including Novartis AG's Sandoz unit, Teva Pharmaceutical Industries Ltd and Mylan Inc, and smaller Indian companies like Lupin Ltd, according to an EMA statement on Friday. Drugs currently being evaluated using studies from the Semler Research Centre Pvt sit…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Hilton lifts 2024 profit forecast on international travel demand
China knockoff raid jolts a global throng of fake-fashion influencers
Roche cuts pipeline after research setbacks and sales drop
Cordlife customers push for legal action
Apparel company Express seeks quick bankruptcy sale
Mattel posts narrower loss, thanks to Hot Wheels growth and lower costs